Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis. [electronic resource]
Producer: 20160205Description: 1289-97 p. digitalISSN:- 1532-1827
- Animals
- Apoptosis -- drug effects
- Bone Neoplasms -- drug therapy
- Caspase 3 -- genetics
- Cell Line, Tumor
- Core Binding Factor Alpha 1 Subunit -- genetics
- Doxorubicin -- pharmacology
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Mice
- Mice, Nude
- Osteosarcoma -- drug therapy
- Proto-Oncogene Proteins c-myc -- genetics
- RNA, Small Interfering -- genetics
- Transcriptional Activation -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.